We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

maandag 14 augustus 2017

Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 20 Issue 3

If you are unable to see the message below, click here to view.
Prostate Cancer and Prostatic Diseases

TABLE OF CONTENTS

Volume 20, Issue 3 (September 2017)

In this issue
Reviews
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Follow PCAN on Twitter Twitter
Recommend to your library
Web feed
Subscribe
Advertisement
Celebrating 20 years of Prostate Cancer and Prostatic Diseases — 1997 to 2017

Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone. 

Watch our anniversary video showing a brief impact overview >>> 
 
 

Reviews

Top

Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed? OPEN

V R Minciacchi, A Zijlstra, M A Rubin and D Di Vizio

Prostate Cancer Prostatic Dis 2017 20: 251-258; advance online publication, April 4, 2017; 10.1038/pcan.2017.7

Abstract | Full Text

Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis

K T Nead, S Sinha and P L Nguyen

Prostate Cancer Prostatic Dis 2017 20: 259-264; advance online publication, March 28, 2017; 10.1038/pcan.2017.10

Abstract | Full Text

A review of pomegranate in prostate cancer

C J Paller, A Pantuck and M A Carducci

Prostate Cancer Prostatic Dis 2017 20: 265-270; advance online publication, April 25, 2017; 10.1038/pcan.2017.19

Abstract | Full Text

Original Articles

Top

ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer—results from an international multicenter study

I Heidegger, H Klocker, R Pichler, A Pircher, W Prokop, E Steiner, C Ladurner, E Comploj, A Lunacek, D Djordjevic, A Pycha, E Plas, W Horninger and J Bektic

Prostate Cancer Prostatic Dis 2017 20: 271-275; advance online publication, March 21, 2017; 10.1038/pcan.2017.3

Abstract | Full Text

Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases

R McKay, B Haider, M S Duh, A Valderrama, M Nakabayashi, M Fiorillo, L Ristovska, L Wen and P Kantoff

Prostate Cancer Prostatic Dis 2017 20: 276-282; advance online publication, February 21, 2017; 10.1038/pcan.2017.4

Abstract | Full Text

Contemporary management of men with high-risk localized prostate cancer in the United States

A B Weiner, R S Matulewicz, E M Schaeffer, S L Liauw, J M Feinglass and S E Eggener

Prostate Cancer Prostatic Dis 2017 20: 283-288; advance online publication, June 20, 2017; 10.1038/pcan.2017.5

Abstract | Full Text

Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database

D Keizman, M O Fosboel, H Reichegger, A Peer, E Rosenbaum, M-C Desax, V Neiman, P M Petersen, J Mueller, R Cathomas, M Gottfried, H Dresler, D Sarid, W Mermershtain, K Rouvinov, J Mortensen, S Gillessen, G Daugaard and A Omlin

Prostate Cancer Prostatic Dis 2017 20: 289-293; advance online publication, February 28, 2017; 10.1038/pcan.2017.6

Abstract | Full Text

Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project

K J Tay, M J Scheltema, H U Ahmed, E Barret, J A Coleman, J Dominguez-Escrig, S Ghai, J Huang, J S Jones, L H Klotz, C N Robertson, R Sanchez-Salas, S Scionti, A Sivaraman, J de la Rosette and T J Polascik

Prostate Cancer Prostatic Dis 2017 20: 294-299; advance online publication, March 28, 2017; 10.1038/pcan.2017.8

Abstract | Full Text

Impact of urologists’ ownership of radiation equipment in the treatment of prostate cancer

S B Williams, J Huo, B F Chapin, B D Smith and K E Hoffman

Prostate Cancer Prostatic Dis 2017 20: 300-304; advance online publication, March 28, 2017; 10.1038/pcan.2017.9

Abstract | Full Text

Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case–control study

N P Papa, R J MacInnis, H Jayasekara, D R English, D Bolton, I D Davis, N Lawrentschuk, J L Millar, J Pedersen, G Severi, M C Southey, J L Hopper and G G Giles

Prostate Cancer Prostatic Dis 2017 20: 305-310; advance online publication, April 18, 2017; 10.1038/pcan.2017.12

Abstract | Full Text

Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach

E J Bass, I A Donaldson, A Freeman, C Jameson, S Punwani, C Moore, M Arya, M Emberton and H U Ahmed

Prostate Cancer Prostatic Dis 2017 20: 311-317; advance online publication, May 9, 2017; 10.1038/pcan.2017.13

Abstract | Full Text

Reduced prostate cancer risk with green tea and epigallocatechin 3-gallate intake among Hong Kong Chinese men

P M Y Lee, C F Ng, Z M Liu, W M Ho, M K Lee, F Wang, H D Kan, Y H He, S S M Ng, S Y S Wong and L A Tse

Prostate Cancer Prostatic Dis 2017 20: 318-322; advance online publication, April 18, 2017; 10.1038/pcan.2017.18

Abstract | Full Text

Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance?

K J Tay, R T Gupta, J Holtz, R K Silverman, E Tsivian, A Schulman, J W Moul and T J Polascik

Prostate Cancer Prostatic Dis 2017 20: 323-327; advance online publication, April 25, 2017; 10.1038/pcan.2017.20

Abstract | Full Text

Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study

H-J Shih, M-C Kao, P-S Tsai, Y-C Fan and C-J Huang

Prostate Cancer Prostatic Dis 2017 20: 328-333; advance online publication, April 11, 2017; 10.1038/pcan.2017.14

Abstract | Full Text

Trends in the use of radiation therapy for stage IIA prostate cancer from 2004 to 2013: a retrospective analysis using the National Cancer Database

T Malouff, N W Mathy, S Marsh, R W Walters and P T Silberstein

Prostate Cancer Prostatic Dis 2017 20: 334-338; advance online publication, April 11, 2017; 10.1038/pcan.2017.15

Abstract | Full Text

Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance

J J Tosoian, H D Patel, M Mamawala, P Landis, S Wolf, D J Elliott, J I Epstein, H B Carter, A E Ross, L J Sokoll and C P Pavlovich

Prostate Cancer Prostatic Dis 2017 20: 339-342; advance online publication, April 18, 2017; 10.1038/pcan.2017.16

Abstract | Full Text

Association of comorbid disease burden at diagnosis with higher tumor grade in men with non-metastatic prostate cancer

T J Daskivich, C J Dru, D Skarecky, T Ahlering and S J Freedland

Prostate Cancer Prostatic Dis 2017 20: 343-347; advance online publication, April 25, 2017; 10.1038/pcan.2017.22

Abstract | Full Text

Multiparametric MRI/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men

M Kongnyuy, M M Siddiqui, A K George, A Muthigi, A Sidana, M Maruf, B Turkbey, P L Choyke, B J Wood and P A Pinto

Prostate Cancer Prostatic Dis 2017 20: 348-351; advance online publication, April 25, 2017; 10.1038/pcan.2017.21

Abstract | Full Text

Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis

R J S Calopedos, V Chalasani, R Asher, L Emmett and H H Woo

Prostate Cancer Prostatic Dis 2017 20: 352-360; advance online publication, April 25, 2017; 10.1038/pcan.2017.23

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature